Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor

Author: Rameshwar P.   Gascon P.   Oh H.S.   Denny T.N.   Zhu G.   Ganea D.  

Publisher: Elsevier

ISSN: 0301-472X

Source: Experimental Hematology, Vol.30, Iss.9, 2002-09, pp. : 1001-1009

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content